Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort by de Castro, Tiago, Welland, Sabrina, Jochheim, Leonie, Leyh, Cathrine, Shmanko, Kateryna, Finkelmeier, Fabian, Jeliazkova, Petia, Jefremow, Andre, Gonzalez-Carmona, Maria A, Kandulski, Arne, Roessler, Daniel, Ben Khaled, Najib, Enssle, Stefan, Venerito, Marino, Fründt, Thorben W, Schultheiß, Michael, Djanani, Angela, Pangerl, Maria, Maieron, Andreas, Wirth, Thomas C, Marquardt, Jens U, Greil, Richard, Fricke, Christina, Günther, Rainer, Schmiderer, Andreas, Bettinger, Dominik, Wege, Henning, Scheiner, Bernhard, Müller, Martina, Strassburg, Christian P, Siebler, Jürgen, Ehmer, Ursula, Waidmann, Oliver, Weinmann, Arndt, Pinter, Matthias, Lange, Christian M, Saborowski, Anna, Vogel, Arndt

Get full text